Literature DB >> 32261379

A platform for nitric oxide delivery.

Jihoon Kim1, Gurusamy Saravanakumar, Hyung Woo Choi, Dongsik Park, Won Jong Kim.   

Abstract

Nitric oxide (NO) is one of the structurally smallest pharmaceutical molecules, which shows great potential as an anti-restenosis, wound healing, anticancer, and antibacterial agent. To date, while most of the studies have focused mainly on demonstrating the versatility of the NO-releasing materials, little effort has been made on developing successful NO-delivery strategies for advancing NO-mediated therapy. Thus, the quest for a rationally designed NO-delivery system is becoming one of the important issues in the biomedical applications of NO. This feature article discusses the overall research trends in the NO-delivery, focusing mainly on the various particle-type and coating platforms. The objective of this article is not only to highlight the fundamental principle and challenges associated with NO-delivery, but also to provide insight for the further development of novel NO-delivery platforms for clinical applications in the near future.

Entities:  

Year:  2013        PMID: 32261379     DOI: 10.1039/c3tb21259a

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  9 in total

1.  Catalyzed Nitric Oxide Release Via Cu Nanoparticles Leads to an Increase in Antimicrobial Effects and Hemocompatibility for Short Term Extracorporeal Circulation.

Authors:  Megan E Douglass; Marcus J Goudie; Jitendra Pant; Priyadarshini Singha; Sean Hopkins; Ryan Devine; Chad W Schmiedt; Hitesh Handa
Journal:  ACS Appl Bio Mater       Date:  2019-05-07

2.  Multifunctional S-Nitroso-N-acetylpenicillamine-Incorporated Medical-Grade Polymer with Selenium Interface for Biomedical Applications.

Authors:  Arnab Mondal; Megan Douglass; Sean P Hopkins; Priyadarshini Singha; Martin Tran; Hitesh Handa; Elizabeth J Brisbois
Journal:  ACS Appl Mater Interfaces       Date:  2019-09-10       Impact factor: 9.229

3.  Poly(cyclodextrin)-Polydrug Nanocomplexes as Synthetic Oncolytic Virus for Locoregional Melanoma Chemoimmunotherapy.

Authors:  Jihoon Kim; Lauren F Sestito; Sooseok Im; Won Jong Kim; Susan N Thomas
Journal:  Adv Funct Mater       Date:  2020-02-24       Impact factor: 18.808

Review 4.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

5.  Quantitative Modeling Extends the Antibacterial Activity of Nitric Oxide.

Authors:  Darshan M Sivaloganathan; Mark P Brynildsen
Journal:  Front Physiol       Date:  2020-04-17       Impact factor: 4.566

6.  Lymph-Directed Self-Immolative Nitric Oxide Prodrug for Inhibition of Intractable Metastatic Cancer.

Authors:  Taejeong Kim; Jeeyeon Suh; Jihoon Kim; Won Jong Kim
Journal:  Adv Sci (Weinh)       Date:  2022-01-05       Impact factor: 17.521

7.  Thermosensitive hydrogel releasing nitric oxide donor and anti-CTLA-4 micelles for anti-tumor immunotherapy.

Authors:  Jihoon Kim; David M Francis; Lauren F Sestito; Paul A Archer; Margaret P Manspeaker; Meghan J O'Melia; Susan N Thomas
Journal:  Nat Commun       Date:  2022-03-18       Impact factor: 14.919

Review 8.  Heavy metal toxicity in plants and the potential NO-releasing novel techniques as the impending mitigation alternatives.

Authors:  Anjali Pande; Bong-Gyu Mun; Nusrat Jahan Methela; Waqas Rahim; Da-Sol Lee; Geun-Mo Lee; Jeum Kyu Hong; Adil Hussain; Gary Loake; Byung-Wook Yun
Journal:  Front Plant Sci       Date:  2022-09-23       Impact factor: 6.627

9.  Endogenous Nitric Oxide-Releasing Microgel Coating Prevents Clot Formation on Oxygenator Fibers Exposed to In Vitro Blood Flow.

Authors:  Patrick Winnersbach; Aisa Hosseinnejad; Thomas Breuer; Tamara Fechter; Felix Jakob; Ulrich Schwaneberg; Rolf Rossaint; Christian Bleilevens; Smriti Singh
Journal:  Membranes (Basel)       Date:  2022-01-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.